Back to Search Start Over

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

Authors :
Shaima’a Hamarsheh
Lena Osswald
Benedikt S. Saller
Susanne Unger
Donatella De Feo
Janaki Manoja Vinnakota
Martina Konantz
Franziska M. Uhl
Heiko Becker
Michael Lübbert
Khalid Shoumariyeh
Christoph Schürch
Geoffroy Andrieux
Nils Venhoff
Annette Schmitt-Graeff
Sandra Duquesne
Dietmar Pfeifer
Matthew A. Cooper
Claudia Lengerke
Melanie Boerries
Justus Duyster
Charlotte M. Niemeyer
Miriam Erlacher
Bruce R. Blazar
Burkard Becher
Olaf Groß
Tilman Brummer
Robert Zeiser
Source :
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Publication Year :
2020
Publisher :
Nature Portfolio, 2020.

Abstract

Oncogenic Ras mutations are common drivers in myeloid leukemia. Here, the authors show in patient cells and in mice that oncogenic K-Ras activates NLRP3 inflammasome to drive myeloproliferation, which can be reversed by genetic or pharmacologic NLRP3 blockade.

Subjects

Subjects :
Science

Details

Language :
English
ISSN :
20411723
Volume :
11
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Nature Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.8d60e15645a540748f0978aece6a6bc5
Document Type :
article
Full Text :
https://doi.org/10.1038/s41467-020-15497-1